Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 29-Mar-24 5:00 PM View:  | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 28-Mar-24 | Private Sale (Planned) | 20,000 | $10.97 | $219,400.00 | (2%) 968.31K to 948.31K | |
| 20-Mar-24 5:30 PM View: | Zojwalla Naseem CHIEF MEDICAL OFFICER | Olema Pharmaceuticals, Inc. (OLMA) | 18-Mar-24 | Option Exercise | 13,700 | $4.87 | $66,719.00 | 21% 66.66K to 80.36K | |
| 06-Mar-24 10:00 PM View: | Rappaport Andrew Director | Olema Pharmaceuticals, Inc. (OLMA) | 05-Mar-24 | Acquisition (other) | 385,965 | -- | -- | 80% 481.01K to 866.98K | |
| 06-Mar-24 10:00 PM View: | Rappaport Andrew Director | Olema Pharmaceuticals, Inc. (OLMA) | 05-Mar-24 | Disposition (other) | 481,014 | -- | -- | (55%) 866.98K to 385.96K | |
| 04-Mar-24 5:30 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 29-Feb-24 | Private Sale (Planned) | 25,000 | $12.41 | $310,309.00 | (3%) 993.31K to 968.31K | |
| 02-Feb-24 5:00 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 01-Feb-24 | Sale (Planned) | 5,000 | $15.56 | $77,800.00 | (< 1%) 998.31K to 993.31K | |
| 02-Feb-24 5:00 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 31-Jan-24 | Private Sale (Planned) | 25,000 | $12.23 | $305,750.00 | (2%) 1.02M to 998.31K | |
| 29-Jan-24 7:30 AM View: | Zojwalla Naseem CHIEF MEDICAL OFFICER | Olema Pharmaceuticals, Inc. (OLMA) | 25-Jan-24 | Option Exercise | 20,000 | $7.02 | $140,400.00 | 43% 46.66K to 66.66K | 2% |
| 16-Jan-24 7:30 AM View: | Kovacs Shane William Charles Ch. Operating & Financial Off. | Olema Pharmaceuticals, Inc. (OLMA) | 12-Jan-24 | Option Exercise | 50,000 | $7.02 | $351,000.00 | 11% 434.99K to 484.99K | 2% |
| 02-Jan-24 5:30 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 29-Dec-23 | Private Sale (Planned) | 25,000 | $13.38 | $334,500.00 | (2%) 1.05M to 1.02M | |
| 12-Dec-23 5:55 PM View: | Kovacs Shane William Charles Ch. Operating & Financial Off. | Olema Pharmaceuticals, Inc. (OLMA) | 12-Dec-23 | Option Exercise | 10,000 | $7.02 | $70,200.00 | 2% 424.99K to 434.99K | 2% |
| 12-Dec-23 5:55 PM View: | Zojwalla Naseem CHIEF MEDICAL OFFICER | Olema Pharmaceuticals, Inc. (OLMA) | 11-Dec-23 | Option Exercise | 2,900 | $7.02 | $20,358.00 | 7% 43.76K to 46.66K | 2% |
| 07-Dec-23 8:30 PM View: | Zojwalla Naseem CHIEF MEDICAL OFFICER | Olema Pharmaceuticals, Inc. (OLMA) | 06-Dec-23 | Option Exercise | 13,100 | $7.02 | $91,962.00 | 43% 30.66K to 43.76K | 2% |
| 08-Dec-23 4:19 PM View: | Paradigm Biocapital Advisor... 10% Owner | Olema Pharmaceuticals, Inc. (OLMA) | 06-Dec-23 | Purchase | 100,000 | $11.60 | $1,160,000.00 | 1% 7.8M to 7.9M | |
| 18-Dec-23 6:30 PM View: | Graham G. Walmsley Director | Olema Pharmaceuticals, Inc. (OLMA) | 05-Dec-23 | Purchase | 131,870 | $14.19 | $1,871,280.00 | 3% 4.25M to 4.38M | |
| 01-Dec-23 5:15 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 30-Nov-23 | Private Sale (Planned) | 25,000 | $12.57 | $314,250.00 | (2%) 1.07M to 1.05M | |
| 22-Nov-23 7:00 PM View: | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Olema Pharmaceuticals, Inc. (OLMA) | 22-Nov-23 | Sale | 6,653 | $13.89 | $92,410.20 | (< 1%) 748.43K to 741.78K | |
| 22-Nov-23 7:00 PM View: | Zojwalla Naseem CHIEF MEDICAL OFFICER | Olema Pharmaceuticals, Inc. (OLMA) | 22-Nov-23 | Sale | 7,095 | $13.89 | $98,549.60 | (19%) 37.76K to 30.66K | |
| 22-Nov-23 7:00 PM View: | Bohen Sean President and CEO Director | Olema Pharmaceuticals, Inc. (OLMA) | 22-Nov-23 | Sale | 27,932 | $13.90 | $388,255.00 | (16%) 172.86K to 144.93K | |
| 22-Nov-23 7:00 PM View: | Kovacs Shane William Charles Ch. Operating & Financial Off. | Olema Pharmaceuticals, Inc. (OLMA) | 22-Nov-23 | Sale | 9,145 | $13.89 | $127,024.00 | (2%) 434.13K to 424.99K | |
| 22-Nov-23 7:00 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 22-Nov-23 | Sale | 3,989 | $13.90 | $55,447.10 | (< 1%) 1.08M to 1.07M | |
| 22-Nov-23 7:00 PM View: | Bohen Sean President and CEO Director | Olema Pharmaceuticals, Inc. (OLMA) | 21-Nov-23 | Sale | 29,293 | $14.88 | $435,879.00 | (14%) 202.15K to 172.86K | |
| 22-Nov-23 7:00 PM View: | Kovacs Shane William Charles Ch. Operating & Financial Off. | Olema Pharmaceuticals, Inc. (OLMA) | 21-Nov-23 | Sale | 9,597 | $14.86 | $142,632.00 | (2%) 443.73K to 434.13K | |
| 22-Nov-23 7:00 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 21-Nov-23 | Sale | 4,192 | $14.86 | $62,293.10 | (< 1%) 1.08M to 1.08M | |
| 22-Nov-23 7:00 PM View: | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Olema Pharmaceuticals, Inc. (OLMA) | 21-Nov-23 | Sale | 6,976 | $14.88 | $103,823.00 | (< 1%) 755.4K to 748.43K | |
| 22-Nov-23 7:00 PM View: | Zojwalla Naseem CHIEF MEDICAL OFFICER | Olema Pharmaceuticals, Inc. (OLMA) | 21-Nov-23 | Sale | 7,461 | $14.84 | $110,747.00 | (16%) 45.22K to 37.76K | |
| 22-Nov-23 7:00 PM View: | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Olema Pharmaceuticals, Inc. (OLMA) | 20-Nov-23 | Grant | 26,250 | -- | -- | 4% 729.15K to 755.4K | |
| 22-Nov-23 7:00 PM View: | Kovacs Shane William Charles Ch. Operating & Financial Off. | Olema Pharmaceuticals, Inc. (OLMA) | 20-Nov-23 | Grant | 36,750 | -- | -- | 9% 406.98K to 443.73K | |
| 22-Nov-23 7:00 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 20-Nov-23 | Grant | 15,750 | -- | -- | 1% 1.07M to 1.08M | |
| 22-Nov-23 7:00 PM View: | Zojwalla Naseem CHIEF MEDICAL OFFICER | Olema Pharmaceuticals, Inc. (OLMA) | 20-Nov-23 | Grant | 28,000 | -- | -- | 163% 17.22K to 45.22K | |
| 22-Nov-23 7:00 PM View: | Bohen Sean President and CEO Director | Olema Pharmaceuticals, Inc. (OLMA) | 20-Nov-23 | Grant | 110,250 | -- | -- | 120% 91.9K to 202.15K | |
| 13-Nov-23 5:30 PM View: | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Olema Pharmaceuticals, Inc. (OLMA) | 08-Nov-23 | Private Sale (Planned) | 200 | $17.61 | $3,522.00 | (< 1%) 729.15K to 728.95K | |
| 03-Nov-23 9:39 PM View: | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Olema Pharmaceuticals, Inc. (OLMA) | 03-Nov-23 | Sale (Planned) | 541 | $17.51 | $9,472.91 | (< 1%) 729.69K to 729.15K | |
| 02-Nov-23 8:50 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 02-Nov-23 | Sale (Planned) | 5,000 | $15.64 | $78,200.00 | (< 1%) 1.07M to 1.07M | |
| 03-Nov-23 9:39 PM View: | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Olema Pharmaceuticals, Inc. (OLMA) | 02-Nov-23 | Sale (Planned) | 3,332 | $15.36 | $51,179.50 | (< 1%) 733.02K to 729.69K | |
| 03-Nov-23 9:39 PM View: | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Olema Pharmaceuticals, Inc. (OLMA) | 01-Nov-23 | Private Sale (Planned) | 6,668 | $15.02 | $100,153.00 | (< 1%) 739.69K to 733.02K | |
| 02-Nov-23 8:50 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 31-Oct-23 | Private Sale (Planned) | 25,000 | $12.05 | $301,250.00 | (2%) 1.1M to 1.07M | |
| 03-Oct-23 5:00 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 29-Sep-23 | Private Sale (Planned) | 25,000 | $12.41 | $310,250.00 | (2%) 1.12M to 1.1M | |
| 21-Sep-23 5:00 PM View: | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Olema Pharmaceuticals, Inc. (OLMA) | 19-Sep-23 | Private Sale (Planned) | 20,000 | $12.67 | $253,400.00 | (3%) 759.69K to 739.69K | |
| 14-Sep-23 4:25 PM View: | Bvf Partners L P/il Director 10% Owner | Olema Pharmaceuticals, Inc. (OLMA) | 14-Sep-23 | Acquisition (other) | 99,556 | -- | -- | 1% 8.8M to 8.9M | |
| 14-Sep-23 4:25 PM View: | Bvf Partners L P/il Director 10% Owner | Olema Pharmaceuticals, Inc. (OLMA) | 12-Sep-23 | Purchase | 1,505,930 | $9.84 | $14,818,400.00 | 21% 7.29M to 8.8M | |
| 18-Dec-23 6:30 PM View: | Graham G. Walmsley Director | Olema Pharmaceuticals, Inc. (OLMA) | 12-Sep-23 | Purchase | 508,130 | $9.84 | $5,000,000.00 | 14% 3.74M to 4.25M | |
| 05-Sep-23 9:08 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 05-Sep-23 | Sale (Planned) | 10,000 | $11.62 | $116,200.00 | (< 1%) 1.13M to 1.12M | |
| 05-Sep-23 9:08 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 31-Aug-23 | Private Sale (Planned) | 15,000 | $9.36 | $140,400.00 | (1%) 1.15M to 1.13M | |
| 17-Aug-23 5:00 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 16-Aug-23 | Private Sale (Planned) | 15,000 | $10.14 | $152,100.00 | (1%) 1.16M to 1.15M | |
| 09-Jun-23 5:30 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 08-Jun-23 | Market Sale | 10,000 | $6.30 | $63,000.00 | (< 1%) 1.17M to 1.16M | (14%) |
| 07-Jun-23 9:30 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 06-Jun-23 | Market Sale | 5,000 | $6.30 | $31,475.00 | (< 1%) 1.18M to 1.17M | (14%) |
| 07-Jun-23 9:30 PM View: | Harmon Cyrus Director | Olema Pharmaceuticals, Inc. (OLMA) | 05-Jun-23 | Market Sale | 5,000 | $6.05 | $30,225.00 | (< 1%) 1.18M to 1.18M | (18%) |
| 07-Apr-23 4:30 PM View: | Kovacs Shane William Charles Ch. Operating & Financial Off. | Olema Pharmaceuticals, Inc. (OLMA) | 06-Apr-23 | Purchase | 10,000 | -- | -- | 3% 386.2K to 396.2K | |
| 22-Sep-22 6:51 PM View: | Bohen Sean President and CEO Director | Olema Pharmaceuticals, Inc. (OLMA) | 21-Sep-22 | Grant | 20,000 | -- | -- | 37% 54.28K to 74.28K |
